The Biomanufacturing and Jobs Act of 2025 amends the Farm Security and Rural Investment Act of 2002 to strengthen the BioPreferred program and grow US biobased markets. It broadens product definitions to include bioproducts, bioattributed products, and plant-based products, and it sets up a Biobased Markets Program that guides federal purchasing, updates procurement targets, and requires transparency through reporting and training.
The bill also creates a BioBased Task Force within the Department of Agriculture to coordinate research, development, promotion, and analysis of biobased products and to deliver a written plan for program improvements. Finally, it adds a labeling framework for biobased and bioproduct categories to support consumer understanding and enforcement.
At a Glance
What It Does
Expands federal biobased procurement targets, adds new product definitions, and creates a labeling framework and reporting requirements within a centralized BioBased Markets Program.
Who It Affects
Federal procurement offices, biobased product manufacturers seeking the USDA label, farmers and feedstock suppliers, and state procurement systems that may align with USDA guidance.
Why It Matters
Establishes governance, measurement, and market incentives to scale domestic biobased manufacturing, reduce petroleum reliance, and strengthen rural economies.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill reorganizes and expands the BioPreferred program by incorporating new product categories and strengthening procurement rules. It requires federal agencies to procure more biobased products over time and to consider product life cycle and performance when making purchases.
It also creates a BioBased Task Force within the Department of Agriculture to coordinate USDA activities, study effectiveness, and issue recommendations for improvements. To support market growth, the bill provides for a public marketing and education program funded by both Federal and non-Federal sources and updates to procurement data systems so biobased purchases are trackable and reportable.
Finally, a new Bioproduct Labeling regime defines terms like biobased product and bioproduct, with enforcement provisions to prevent mislabeling while protecting confidential business information.
The Five Things You Need to Know
The bill broadens product definitions to include biobased and bioattributed products, as well as plant-based products.
Annual procurement targets for biobased products must be updated to increase volumes or contracts.
A new BioBased Task Force within USDA coordinates programs, conducts a study, and reports findings within three years.
A labeling framework and prohibited-use rules will govern how biobased terms are used on products.
Federal procurement data systems and training requirements will improve oversight and market visibility.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short Title
Be it enacted as the Biomanufacturing and Jobs Act of 2025. This section establishes the official citation for the Act and confirms its placement within the 119th Congress framework.
Findings and Purposes
This section documents Congress’s findings on the value of biobased products for farm income, rural development, and diversification away from petroleum. It also sets out the purposes: to promote domestic biobased manufacturing, to expand procurement programs, and to commit to rural economies through a more robust bioproduct market.
Definitions
The bill adds key terms: bioattributed product, bioproduct, biobased plastic, plant-based product, and related definitions. It clarifies how these terms fit into the BioPreferred program and how they relate to biobased labeling and procurement standards.
Biobased Markets Program
Section 9002 expands procurement preferences by requiring annual increases in biobased purchases and establishing price premium considerations. It creates agency guidance on life cycle, savings, and efficacy, and requires agencies to train staff and to update procurement catalogs and reporting systems. The section also imposes reporting requirements and potential use of non-Federal funds for public marketing and education.
BioBased Task Force
Section 9004 establishes a USDA task force to coordinate research, development, promotion, marketing, and analysis of biobased products. It defines membership from multiple USDA mission areas, assigns leadership to rural development, requires public input, and mandates a final progress report within three years before the program ends.
Bioproduct Labeling
Section 9009 creates a labeling framework for bio-based terms, allows alternate definitions, and prohibits mislabeling. It also includes confidentiality protections for business information and outlines enforcement mechanisms in coordination with the Attorney General.
This bill is one of many.
Codify tracks hundreds of bills on Economy across all five countries.
Explore Economy in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Biobased product manufacturers seeking the USDA label and access to federal contracts, enabling expanded market opportunities.
- Farmers and feedstock suppliers (e.g., corn and soy) benefiting from stronger demand for biobased feedstocks.
- Rural development agencies and regional economic partners that gain tools to promote agricultural economies and job growth.
- Federal procurement officials and contracting officers who gain clearer rules, data systems, and lifecycle considerations for purchasing decisions.
- State and local procurement offices that may align practices with federal biobased procurement guidance.
Who Bears the Cost
- Federal agencies will incur costs to implement new procurement procedures, training, and reporting requirements.
- Biobased product manufacturers may face costs to meet labeling standards and to adapt products for labeling compliance.
- The federal data systems and catalog updates will require IT resources and interoperability work across agencies.
- Private sector marketing activities funded by non-Federal contributions may shift costs toward industry and philanthropic partners.
- The process of enforcing labeling rules will require enforcement resources and potential investigations into mislabeling.
Key Issues
The Core Tension
The central tension is balancing rapid expansion of biobased markets and strict labeling/enforcement with the practical constraints of federal procurement operations, industry readiness, and data standardization. The bill seeks to grow markets through procurement mandates and labeling, but doing so risks misalignment if definitions, standards, and enforcement rules are not consistently implemented across agencies and product categories.
The bill creates a broad, multi-year program to scale biobased markets, but it raises several implementation questions. The interplay between new definitions and existing FDA/USDA labeling practices could create compliance ambiguity for manufacturers until regulations stabilize.
The reliance on non-Federal funds for public marketing raises questions about sustainability and governance of outreach, including how contributors influence messaging and accountability. Updating procurement data systems and ensuring consistent life-cycle assessments across agencies will require significant coordination and funding, including alignment with established standards like ASTM D6866.
Finally, the termination of the task force after four years invites questions about long-term program durability and the continuity of policy learning.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.